Literature DB >> 23704222

FOLFIRINOX in locally advanced pancreas adenocarcinoma: back to the future?

Tanios Bekaii-Saab1, Richard M Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23704222      PMCID： PMC3662837          DOI： 10.1634/theoncologist.2013-0157

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  13 in total

1.  FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience.

Authors:  Jason E Faris; Lawrence S Blaszkowsky; Shaunagh McDermott; Alexander R Guimaraes; Jackie Szymonifka; Mai Anh Huynh; Cristina R Ferrone; Jennifer A Wargo; Jill N Allen; Lauren E Dias; Eunice L Kwak; Keith D Lillemoe; Sarah P Thayer; Janet E Murphy; Andrew X Zhu; Dushyant V Sahani; Jennifer Y Wo; Jeffrey W Clark; Carlos Fernandez-del Castillo; David P Ryan; Theodore S Hong
Journal:  Oncologist       Date:  2013-05-08

2.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

Review 3.  Update on the optimal management of patients with colorectal liver metastases.

Authors:  Steven R Alberts
Journal:  Crit Rev Oncol Hematol       Date:  2012-03-17       Impact factor: 6.312

4.  Understanding metastasis in pancreatic cancer: a call for new clinical approaches.

Authors:  David A Tuveson; John P Neoptolemos
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

5.  Surgical implication of micrometastasis for pancreatic cancer.

Authors:  Masato Kayahara; Kennichiro Funaki; Hidehiro Tajima; Hiroyuki Takamura; Itasu Ninomiya; Hirohisa Kitagawa; Tetsuo Ohta
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

6.  Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.

Authors:  Florence Huguet; Thierry André; Pascal Hammel; Pascal Artru; Jacques Balosso; Frédéric Selle; Elisabeth Deniaud-Alexandre; Philippe Ruszniewski; Emmanuel Touboul; Roberto Labianca; Aimery de Gramont; Christophe Louvet
Journal:  J Clin Oncol       Date:  2007-01-20       Impact factor: 44.544

7.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

8.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

9.  Potential regional differences for the tolerability profiles of fluoropyrimidines.

Authors:  Daniel G Haller; Jim Cassidy; Stephen J Clarke; David Cunningham; Eric Van Cutsem; Paulo M Hoff; Mace L Rothenberg; Leonard B Saltz; Hans-Joachim Schmoll; Carmen Allegra; Joseph R Bertino; Jean-Yves Douillard; Bengt G Gustavsson; Gerard Milano; Michael O'Connell; Youcef Rustum; Josep Tabernero; Frank Gilberg; Florin Sirzén; Chris Twelves
Journal:  J Clin Oncol       Date:  2008-05-01       Impact factor: 44.544

10.  A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

Authors:  Peter J Hosein; Jessica Macintyre; Carolina Kawamura; Jennifer Cudris Maldonado; Vinicius Ernani; Arturo Loaiza-Bonilla; Govindarajan Narayanan; Afonso Ribeiro; Lorraine Portelance; Jaime R Merchan; Joe U Levi; Caio M Rocha-Lima
Journal:  BMC Cancer       Date:  2012-05-29       Impact factor: 4.430
View more
  1 in total

1.  A mathematical model for pancreatic cancer growth and treatments.

Authors:  Yoram Louzoun; Chuan Xue; Gregory B Lesinski; Avner Friedman
Journal:  J Theor Biol       Date:  2014-03-01       Impact factor: 2.691
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.